Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump Administration's Rx-Price-Disclosure Reg Sets Up Legal Fight With PhRMA

Executive Summary

From kinds of ads targeted to agency that's issuing the reg, policy seems designed to withstand a court challenge.
Advertisement

Related Content

First Amendment Challenge To DTC Rule Unlikely From Industry; For Now, It Is 'Comply With Context'
DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar
DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar
DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition
DTC Price Disclosure Should Include Cost Sharing Context, Patient Groups Tell CMS
US Drug Pricing: CMS Seeks Feedback On DTC Ad Enforcement Mechanism, Disclosure Statement
Trump Administration's Rx Drug Price Disclosure Reg Seen As Unworkable
DTC Advertising: The 'Kick Me' Sign On Big Pharma’s Backs
J&J Supports ‘Spirit’ Of DTC Pricing Transparency, But Prefers PhRMA’s Voluntary Approach
Government Action/Industry Reaction: HHS Sees Success In Approach To Drug Pricing Solutions

Topics

Advertisement
UsernamePublicRestriction

Register

PS124070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel